Arkolith/Insider Trading/COEP/Form 4

Salkind Gene

DirectorCoeptis Therapeutics Holdings, Inc. (COEP) · full profile →Form 4 · filed Jan 9, 2024
Net Buying
Open-Market Buys
$8K
Open-Market Sells
$0
Net Open-Market Flow
$8K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2024Buy(P)12K$0.69$8K284K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-24-000161) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML